Last updated: December 1, 2021
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Overall Status: Completed
Phase
N/A
Condition
Chest Pain
Myocardial Ischemia
Hypercholesterolemia
Treatment
N/AClinical Study ID
NCT00929227
090164
09-H-0164
Ages 18-100 All Genders
Study Summary
Eligibility Criteria
Inclusion
- GENERAL INCLUSION CRITERIA:
- 18 years of age and older
- Prior equivocal stress study within the preceding 90 days
- Able to provide informed consent
Exclusion
MEDICAL EXCLUSION CRITERIA:
- Decompensated heart failure (unable to lie flat during MRI or CT)
- Severe kidney disease (MDRD estimated Glomerular Filtration Rate less than 30mL/min/1.73m(2).
- Prior cardiac revascularization with coronary stent or bypass surgery
- Resting tachycardia (HR greater than l00 bpm)
- Pregnant women (when uncertain, subjects will undergo urine or blood testing)
- Lactating women (unless they are willing to discard breast milk for 24 hours afterreceiving gadolinium)
- Second (Type II) and third degree atrioventricular heart block
- Asthma or chronic pulmonary disease (emphysema) actively treated with bronchodilatorsor leukotriene antagonists MRI EXCLUSION CRITERIA:
- Cardiac pacemaker or implantable defibrillator
- Cerebral aneurysm clip
- Neural stimulator (e.g. TENS-Unit)
- Any type of ear implant
- Ocular foreign body (e.g. metal shavings)
- Any implanted device (e.g. insulin pump, drug infusion device)
- Metal shrapnel or bullet
Study Design
Total Participants: 109
Study Start date:
July 01, 2009
Estimated Completion Date:
November 19, 2020
Study Description
Connect with a study center
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland 20892
United StatesSite Not Available
Suburban Hospital
Bethesda, Maryland 20814
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.